Cvs Health (CVS) Shares Outstanding (Weighted Average) (2009 - 2026)

Cvs Health has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 0.95% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 0.95% YoY), and the FY2025 full-year result was $1.3 billion, up 0.64% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $1.3 billion in Q3 2022, with the low at $1.3 billion in Q2 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2026.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) declined 2.36% — and 2026, when it climbed 0.95%.
• Cvs Health's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then slipped by 2.06% to $1.3 billion in 2023, then declined by 2.02% to $1.3 billion in 2024, then increased by 0.64% to $1.3 billion in 2025, then rose by 0.47% to $1.3 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.